Skip to main content

Find Clinical Trials

Home
Conditions
Partial Response of Multiple Myeloma or Plasma Cell Leukemia

Clinical trial condition

Partial Response of Multiple Myeloma or Plasma Cell Leukemia

Explore clinical trials studying Partial Response of Multiple Myeloma or Plasma Cell Leukemia. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Partial Response of Multiple Myeloma or Plasma Cell Leukemia trial results

Active, Not Recruiting

SVN53-67/M57-KLH Peptide Vaccine in Treating Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide Maintenance Therapy

NCT02334865

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

University of Rochester Medical Center Rochester, New York, United States

View Trial Details